VACHW Voyager Acquisition Corp./Cayman Islands

Nasdaq Biological Products, (No Diagnostic Substances) E9 CIK: 0002006815
AI RATING
STRONG_SELL
92% Confidence

Investment Thesis

Voyager Acquisition Corp faces critical financial distress with negative stockholders' equity (-$13.1M), indicating technical insolvency. The company exhibits a severe liquidity crisis (0.15x current ratio), minimal cash reserves ($182K), and negative operating cash flow (-$486K) with no visible revenue base. The positive net income is anomalous and likely non-operating, obscuring underlying operational deterioration.

Strengths

  • + Retains asset base of $270.1M despite negative equity
  • + Positive net income of $9.0M indicates some value-creation events (though source unclear)
  • + Company structure and operations remain functional despite distress

Risks

  • ! Negative stockholders' equity of -$13.1M indicates technical insolvency and balance sheet insolvency
  • ! Critical liquidity crisis with current ratio of 0.15x and cash reserves under $200K
  • ! Negative operating cash flow and no visible revenue generation indicate ongoing cash burn without sustainable operations
  • ! Anomalous net income likely from non-operating sources, masking core business deterioration
  • ! Zero insider trading activity suggests lack of internal confidence

Key Metrics to Watch

Financial Metrics

Revenue
N/A
Net Income
9.0M
EPS (Diluted)
$0.24
Free Cash Flow
-486.2K
Total Assets
270.1M
Cash
182.1K

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA 3.3%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
0.15x
Quick Ratio
0.15x
Debt/Equity
N/A
Debt/Assets
4.9%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-18T11:30:24.301353 | Data as of: 2025-12-31 | Powered by Claude AI